Sun Pharma Executive and Leadership Team

Abhay Gandhi, the Chief Executive Officer (North America) at Sun Pharma, directs all commercial operations and market expansion initiatives across the United States and Canada. Gandhi manages the complex generic drug portfolio, ensuring that specialty medicines reach healthcare providers and patients efficiently. By overseeing regional supply chain logistics and regulatory compliance, the Chief Executive Officer (North America) maintains high standards for product distribution. This leadership role involves constant collaboration with the global research and development teams to align product launches with North American market demands. Through strategic oversight of regional sales performance, Abhay Gandhi drives revenue growth and strengthens the competitive position of the company. The Chief Executive Officer (North America) also monitors market trends to identify new opportunities for portfolio diversification, ensuring that the organization remains a leader in the highly competitive pharmaceutical landscape of the region.

Joseph Gerald, the Chief Executive Officer, Business Super Cluster 2 (India) at Sun Pharma, oversees the manufacturing and distribution of pharmaceutical formulations within the domestic Indian market. Gerald manages large-scale production facilities, ensuring that active pharmaceutical ingredients meet stringent quality benchmarks. By coordinating with local regulatory bodies, the Chief Executive Officer, Business Super Cluster 2 (India) facilitates the seamless delivery of essential medications to diverse patient populations. This leadership role requires balancing high-volume generic production with the development of specialized therapeutic solutions. Through the optimization of regional manufacturing processes, Joseph Gerald enhances operational efficiency and reduces time-to-market for critical drug products. The Chief Executive Officer, Business Super Cluster 2 (India) also drives initiatives to improve supply chain resilience, ensuring that the company maintains a dominant presence in the Indian pharmaceutical sector while supporting broader corporate growth objectives.

Kay Patel, the Chief Executive Officer Office at Sun Pharma, coordinates executive communications and facilitates strategic alignment across all global business units. Patel manages the flow of critical information between the leadership team and the board, ensuring that corporate objectives remain clear and actionable. By overseeing administrative workflows and high-level project tracking, the Chief Executive Officer Office supports the execution of long-term pharmaceutical development goals. This leadership role involves managing cross-functional initiatives that bridge the gap between research, manufacturing, and commercial departments. Through the implementation of streamlined reporting structures, Kay Patel enhances organizational transparency and decision-making speed. The Chief Executive Officer Office also monitors the progress of key strategic projects, ensuring that all departments remain focused on the core mission of delivering high-quality specialty medicines to global markets while maintaining operational excellence throughout the entire enterprise.

Richard Ascroft, the Chief Executive Officer (North America) at Sun Pharma, focuses on the strategic integration of specialty medicines into the North American healthcare ecosystem. Ascroft manages relationships with key stakeholders, including pharmacy benefit managers and hospital networks, to ensure broad access to the company's diverse drug portfolio. By overseeing the commercialization of complex generics, the Chief Executive Officer (North America) drives market penetration and brand recognition. This leadership role involves analyzing regional competitive dynamics to refine pricing strategies and product positioning. Through the management of cross-functional teams, Richard Ascroft ensures that marketing efforts align with clinical data and regulatory requirements. The Chief Executive Officer (North America) also evaluates potential partnerships to expand the company's footprint in the region, ultimately supporting the goal of providing affordable, high-quality pharmaceutical solutions to patients across the North American market.

Akshay Sethi, the Group Chief Financial Officer at Sun Pharma, manages the global financial health and capital allocation strategies of the organization. Sethi oversees financial planning, reporting, and risk management, ensuring that the company maintains a strong balance sheet to support ongoing research and development. By directing investment strategies for new pharmaceutical technologies, the Group Chief Financial Officer facilitates long-term growth and market expansion. This leadership role involves coordinating with regional financial heads to ensure fiscal discipline across all international operations. Through the optimization of capital structures, Akshay Sethi supports the company's ability to scale manufacturing capabilities and enter new therapeutic areas. The Group Chief Financial Officer also provides critical insights to the board regarding financial performance and market trends, ensuring that the organization remains financially resilient while pursuing its mission of delivering high-quality medicines to patients worldwide.

Jayashree Satagopan, the Global Chief Financial Officer at Sun Pharma, oversees the enterprise-wide financial strategy, including treasury operations, tax planning, and investor relations. Satagopan manages the financial integration of global acquisitions, ensuring that new assets align with the company's core pharmaceutical manufacturing model. By directing the budgeting process for research and development, the Global Chief Financial Officer ensures that innovation remains a top priority while maintaining profitability. This leadership role involves analyzing global market volatility to mitigate financial risks and protect shareholder value. Through the implementation of robust financial controls, Jayashree Satagopan enhances the transparency and efficiency of the company's fiscal operations. The Global Chief Financial Officer also collaborates with the executive team to evaluate strategic opportunities for portfolio expansion, ensuring that the organization possesses the necessary resources to continue its mission of providing accessible, high-quality specialty medicines to patients globally.

Faried Niamut, the Manager, Quality Assurance & Chief Marketing Officer, Biologics & Pharma Branded at Sun Pharma, directs the quality control protocols for all biologics and branded pharmaceutical products. Niamut ensures that every stage of the manufacturing process adheres to international safety standards and regulatory requirements. By overseeing the marketing strategy for the branded portfolio, the Manager, Quality Assurance & Chief Marketing Officer, Biologics & Pharma Branded drives product adoption among healthcare professionals. This leadership role involves bridging the gap between rigorous quality assurance and commercial success. Through the implementation of advanced testing methodologies, Faried Niamut maintains the integrity of the company's specialized drug offerings. The Manager, Quality Assurance & Chief Marketing Officer, Biologics & Pharma Branded also collaborates with research teams to communicate the clinical benefits of new biologics, ensuring that the company remains at the forefront of pharmaceutical innovation and patient safety.

Suresh Rai, the Global Chief Human Resources Officer at Sun Pharma, directs the talent acquisition, organizational development, and employee engagement strategies across all global locations. Rai oversees the cultivation of a high-performance culture that supports the company's research and manufacturing objectives. By implementing comprehensive training programs, the Global Chief Human Resources Officer ensures that the workforce remains equipped with the skills necessary to navigate the evolving pharmaceutical industry. This leadership role involves aligning human capital strategies with the company's broader business goals, including expansion into new markets. Through the management of global compensation and benefits, Suresh Rai fosters an environment that attracts and retains top-tier scientific and commercial talent. The Global Chief Human Resources Officer also leads diversity and inclusion initiatives, ensuring that the organization benefits from a wide range of perspectives while maintaining a unified focus on delivering life-saving medications.

Madhavi Patel, the Administrative Assistant To the Chief Marketing Officer and Project Coordinator. Medical Affairs at Sun Pharma, manages the operational workflows and project timelines for the medical affairs department. Patel coordinates cross-departmental communication, ensuring that clinical data and marketing initiatives remain synchronized. By overseeing the scheduling and documentation for key medical affairs projects, the Administrative Assistant To the Chief Marketing Officer and Project Coordinator. Medical Affairs supports the efficient delivery of scientific information to healthcare providers. This leadership role involves managing complex administrative tasks that facilitate the smooth operation of the marketing and medical affairs teams. Through the organization of project resources, Madhavi Patel ensures that the company effectively communicates the value of its specialty medicines. The Administrative Assistant To the Chief Marketing Officer and Project Coordinator. Medical Affairs also tracks project milestones, ensuring that all medical affairs activities align with the company's overarching strategic goals.

Gustavo Umpierrez, the Chief Marketing Officer, Project Lead at Sun Pharma, directs the global marketing strategy and leads high-priority projects aimed at expanding the company's market share. Umpierrez oversees the development of brand positioning for specialty medicines, ensuring that the company's value proposition resonates with healthcare providers and patients. By managing the execution of strategic marketing campaigns, the Chief Marketing Officer, Project Lead drives product awareness and adoption in key therapeutic areas. This leadership role involves coordinating with regional teams to tailor marketing efforts to local market nuances. Through the analysis of market data and consumer insights, Gustavo Umpierrez optimizes the company's promotional activities to maximize impact. The Chief Marketing Officer, Project Lead also leads cross-functional project teams to launch new products, ensuring that all marketing initiatives support the company's mission of delivering high-quality, accessible pharmaceutical solutions to a global patient base.